glp 1 with 3 receptors glp-1_analogs [TUSOM Glucagon-like peptide-1 receptor: mechanisms and

The study evaluated outcomes over a 48-week period, including changes in body weight, waist circumference, glycemic markers, and lipid profiles

Recent studies suggest the answer may be yes

Some muscles shrank slightly, but others stayed the same, and strength varied independently of size

Health Psychol Open

Thus, whilst the CVOTs provide valuable and supportive evidence of a benefit of GLP-1 RAs on HF in people with type 2 diabetes, additional trials are required to fully understand the magnitude and nature of such a potential effect, including if it applies to both prevention and treatment of the condition

GLP-1 therapy has also shown benefit in improving atherothrombosis markers (e.g., inflammation, endothelial dysfunction, clotting in this population